Differentiated pancreatic tumor cells highly express c-MYC and, hence, exhibit low levels of PGC-1α; however, in cancer stem cells (CSCs), c-MYC is not highly expressed and PGC-1α levels are amplified [141]. Here, PPARGC1A is linked to pancreatic neoplasm.